• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. G2 FILTER SYSTEM - FEMORAL; VENA CAVA FILTER Back to Search Results
Catalog Number RF310F
Device Problems Detachment of Device or Device Component (2907); Material Deformation (2976); Patient Device Interaction Problem (4001)
Patient Problem Foreign Body In Patient (2687)
Event Date 01/25/2019
Event Type  Injury  
Manufacturer Narrative
Manufacturing review: the device history records have been reviewed with special attention to the raw materials, subassemblies, manufacturing process, and quality control testing.This lot met all release criteria.There was nothing found to indicate there was a manufacturing related cause for this event.Investigation summary: the device was not returned for evaluation.Medical records were provided and reviewed.Approximately nine years and one month later, the patient presented for filter removal, right common femoral vein access and right internal jugular vein access were made.Inferior vena cavogram revealed the filter was tilted to the top right approximately 11 degrees.Multiple legs extend beyond the wall of the inferior vena cava.The filter was positioned below the level of the renal veins.Considering filter tilt and the lack of a hook along the top cap for snaring, the decision was made to use sterile rigid endobronchial forceps for retrieval.Rosen wire was advanced through the omni flush catheter which was exchanged for a 10-french dilator.The tract was dilated, and then serial dilation was performed up to 14-french.A 16-french by 45 cm sheath was flushed and advanced over the guidewire under fluoroscopic guidance into the inferior vena cava just above the superior aspect of the filter.Sterile bronchial forceps were placed through the sheath superior to the filter hook.The forceps were used to gently dissect the top cap of the filter off the wall of the cave.Multiple obliquities were used to guide the forceps exactly to the top cap.During dissection, one of the filter struts was noted to be bent superiorly.This strut was brought into the sheath and dissection continued.The filter top cap was grasped with the forceps and freed from the inferior vena cava wall.This allowed the sheath to be advanced over the filter and dislodged the legs from the inferior vena cava wall.The forceps and filter were removed through the sheath.The filter was inspected and one of the struts was noted to be absent.Gross description revealed, the filter was 4.0 x 3.5 x 3.5 cm.Fluoroscopy was then used to locate the strut which had embolized into the chest.Pulmonary arteriogram revealed the filter component embolization to the chest, with the embolized strut overlying the right upper lung/mediastinum, a 5-french catheter was advanced through the groin sheath and under fluoroscopic guidance advanced into the right ventricular outflow tract and into the main pulmonary artery.Digital subtraction angiography revealed patency of the right pulmonary arterial tree without evidence for strut embolization within the pulmonary artery.The strut appeared to be inferior to the right pulmonary artery.Superior venacavogram revealed the strut positioned posterior to the superior vena cava.On the next day, computed tomography angiography of cardiac revealed, the filter strut was extravascular in location, positioned in the mediastinal fat posterior to the left main pulmonary artery and extended inferolaterally with the distal strut abutted and closely associated with the posterior wall of the right superior pulmonary vein.The majority of the strut was stable to be extravascular, distal and inferior 7 mm portion of the filter strut intimately associated with the right superior pulmonary vein as a possible intravascular location.On the same day, computed tomography of chest without contrast revealed, the metallic fragment extends along the posterior aspect of the right superior pulmonary vein proximally and terminated in the mediastinum just anterior to the esophagus and immediately adjacent to the left atrium.Intraoperative consultation was requested from the cardiothoracic surgery service.Given the lack of additional movement of the embolized right and the patient's hemodynamic stability, the decision was made to terminate the procedure.Therefore, the investigation is confirmed for the alleged perforation of the inferior vena cava, filter limb detachment and material deformation.Based on the available information, the definitive root cause is unknown.Labeling review: a review of product labeling documents (e.G.Procedural instructions, indications, warnings, precautions, cautions, possible complications, contraindications, and unit label) showed that the product labeling is adequate.(expiry date: 09/2012).
 
Event Description
It was reported through the litigation process that a vena cava filter was placed in a patient after being diagnosed with deep vein thrombosis.Approximately nine years and one month post filter deployment, it was alleged that the filter struts perforated, bent superiorly, and detached.The device was removed percutaneously.The patient reportedly experienced embolized strut overlay the right upper lung/mediastinum; however, the current status of the patient is unknown.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G2 FILTER SYSTEM - FEMORAL
Type of Device
VENA CAVA FILTER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
Manufacturer (Section G)
C.R. BARD, INC. (GFO)
289 bay road
queensbury NY 12804
Manufacturer Contact
judith ludwig
1415 w. 3rd street
tempe, AZ 85281
4803032689
MDR Report Key11981824
MDR Text Key255592683
Report Number2020394-2021-80502
Device Sequence Number1
Product Code DTK
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K062887
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer,health professional
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 06/11/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/11/2021
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue NumberRF310F
Device Lot NumberGFTG3548
Was Device Available for Evaluation? No
Date Manufacturer Received06/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/26/2009
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age34 YR
Patient Weight53
-
-